On average, the above 10 stocks were UP 7.4% during the first week of May but are now DOWN 7.6%...
A medical cannabis pilot program was left out of the final bill. The post Biden Approves Funding for Psychedelic Drug Research for Military Members appeared...
The company is a going concern, with a cumulative deficit of $4,132,349 as of August 31. The post PharmAla Biotech Reports Progress in Earnings appeared...
The state should easily eclipse $3 billion in total sales for the year. The post Michigan Marijuana Industry Could Clear Its Biggest Hurdle Yet in 2024...
The firm managed to find adequate research funding over the year as sale talks emerged. The post Tryp Therapeutics Lowers Losses in 2023; Sees New Era...
PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: PMBHF)released its audited financial statements in Canadian dollars for the year ended on August 31, 2023....
This story was republished with permission from Crain’s Detroit and written by Dustin Walsh. Michigan became the nation’s dominant marijuana market...
From Calibre Mining to Atha Energy, Mugglehead covered more than 1,500 stories in 2023 The post Mugglehead Magazine’s Top 10 Stories of 2023 appeared...
The global demographic shift, marked by a decline in birth rates and an increase in aging populations, has posed a significant strain on healthcare resources....
Microdose takes a look back at some of the top psychedelic stories of 2023. The post The Top Psychedelic Stories of 2023 appeared first on Microdose.
Take a look at this 2023 search volume chart. Do you think you can guess what’s happening? I was pretty shocked when I noticed this spike...
It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most...
We take a deeper look at ancient shamanic traditions, exploring how magic mushrooms may be a part of Christmas history. The post Santa’s Trippy Origins:...
Here's a look back at the good news of the past year. The post The Best Things that Happened to Cannabis in 2023 appeared first on...
Awakn Life Sciences (OTC: AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction,...
Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological...